Crain’s Cleveland Business: Joseph Jankowski, chief innovation officer in the Office of Research and Technology Management, discussed how there can be a long turnaround in seeing an advance in drug development being implemented for patients.

Office of Research and Technology Management’s Joseph Jankowski discusses timeline for drug developments to be seen at patient level
MEDIA |
September 9, 2019
STORY BY: EDITORIAL STAFF
STORY BY: EDITORIAL STAFF